期刊文献+

阿司匹林促进大鼠缺血脑组织脑源性神经营养因子的表达 被引量:4

Aspirin Mediates Endogenous Brain Derived Neurotrophic Factor Expression Against Focal Cerebral Ischemia in Rat Model
原文传递
导出
摘要 目的:探讨不同剂量阿司匹林(Asp)对脑缺血/再灌注(CI/RP)损伤大鼠的神经保护作用及其对脑源性神经营养因子(BDNF)表达的影响。方法:采用线栓法建立大鼠大脑中动脉CI/RP模型,对CI/RP后大鼠进行肢体神经功能缺损评分:1~3分的48只大鼠入选。入选大鼠分为对照组、Asp小剂量组(20 mg.kg-1)、Asp中剂量组(80 mg.kg-1)和Asp大剂量组(320 mg.kg-1),于CI/RP术后每日腹腔注射Asp或溶媒,并进行神经功能缺损评分,72 h后处死,测定脑梗死体积和BDNF免疫组化检测。结果:CI/RP后24、48和72 h各Asp组大鼠与对照组相比,神经缺损评分明显降低(P〈0.05或P〈0.01),梗死灶体积显著减小(P〈0.01),缺血区域BDNF表达显著增加(P〈0.05或P〈0.01)。对BDNF表达的作用Asp大剂量组的作用并不优于Asp小剂量组和中剂量组。结论:Asp可以减少CI/RP大鼠的脑梗死体积;促进内源性BDNF的表达可能是其神经保护的机制之一,Asp对BDNF表达的作用并非随Asp剂量的加大而增强。 Aim:To investigate the neurorotective effect of aspirin(Asp) on the expression of the brain derived neurotrophic factor(BDNF) after reversible focal cerebral ischemia.Methods:MCA cerebral ischemia/reperfusion(CI/RP) rat model was established with suture occlusion technique.The modeling rats were randomly divided into four groups:one control group and three Asp groups with different doses(low dose:20 mg·kg-1,middle dose:80 mg·kg-1 and high dose:320 mg·kg-1).Asp was administered intraperitoneally right after CI/RP and the next 2 days respectively.The neurological deficit scores were recorded continuously for four days.The rats were then killed at 72 h after CI/RP,and the whole brain was removed to measure the infarct volume and expression of BDNF by immunohistochemistry.Results:Compared with the control group,individual in Asp groups showed decreased neurological deficit scores(P0.05 or P0.01),reduced brain infarct volumes(P0.01) and elevated expression of BDNF(P0.05 or P0.01).Also,the effect of high dose of Asp was not superior to the low or middle dose.Conclusion:Asp could reduce the brain infarct volume and its up-regulation of endogenous BDNF expression might be the one of mechanisms of protective effects after focal cerebral ischemia.
出处 《中国临床神经科学》 2011年第4期347-351,共5页 Chinese Journal of Clinical Neurosciences
基金 辽宁省科技攻关项目资助(编号:2004225003-16)
关键词 阿司匹林 脑缺血/再灌注 神经保护 脑源性神经营养因子 aspirin focal cerebral ischemia neuroprotection brain derived neurotrophic factor
  • 相关文献

参考文献18

  • 1徐涛,曲方.阿司匹林的神经保护作用[J].中国临床神经科学,2004,12(2):220-222. 被引量:7
  • 2陈英辉.脑源性神经营养因子和脑缺血[J].中国临床神经科学,2000,8(2):142-144. 被引量:9
  • 3Panford-Walsh R, Singer W, Ruttiger L, et al. Midazolam reverses salicylate-induced changes in brain-derived neurotrophic factor and arg3.1 expression: implications for tinnitus perception and auditory plasticity[J]. Mol Pharmacol,2008,74:595-604.
  • 4Singer W, Panford-Walsh R, Watermann D, et al. Salicylate alters the expression of calcium response transcription factor 1 in the cochlea: implications for brain-derived neurotrophic factor tran- scriptional regulation[J]. Mol Pharmacol,2008,73:1085-1091.
  • 5Longa EZ, Weinstein PR, Carlson S, et al. Reversible middle cerebral artery occlusion without craniectomy in rats[J]. Stroke,1989,20:84-91.
  • 6Bederson JB, Pitts LH, Tsuji M, et al. Rat middle cerebral artery occlusion evaluation of the model and development of a neuro- logic examination[J]. Stroke,1986,17:472-476.
  • 7中华人民共和国卫生部药典委员会.药品标准[M].二部,1995:105.
  • 8Lin TN, He YY, Wu G, et al. Effect of brain edema on infarct volume in a focal cerebral ischemia model in rats[J]. Stroke,1993,24:117-121.
  • 9徐涛,曲方,周中和,宋福林.阿司匹林对脑缺血-再灌注损伤大鼠神经保护作用的机制[J].中国脑血管病杂志,2006,3(6):267-272. 被引量:8
  • 10刘兴,曲方.大鼠脑缺血/再灌注后Fasl在脑内表达的变化和阿司匹林的干预作用[J].中国临床神经科学,2006,14(6):594-599. 被引量:6

二级参考文献119

  • 1蒋祝昌,毕桂南,石胜良.高血压大鼠局灶性脑缺血再灌注后Survivin及Bcl-2表达[J].中国临床神经科学,2005,13(2):127-130. 被引量:6
  • 2徐涛,曲方,周中和,宋福林.阿司匹林对脑缺血-再灌注损伤大鼠神经保护作用的机制[J].中国脑血管病杂志,2006,3(6):267-272. 被引量:8
  • 3De Cristóbal J,Cárdenas A,Lizasoain I,et al.lnhibition of glutamate release via recovery of ATP levels accounts for a neuroprotective effect of aspirin in rat cortical neurons exposed to oxygen-glucose deprivation[J].Stroke,2002,33:261-267
  • 4De Cristóbal J,Madrigal JLM,Lizasoain l,et al.Aspirin inhibits stress-induced increase in plasma glutamate,brain oxidative damage and ATP fall in rats[J].Neuroreport,2002,13:217-221
  • 5Grilli M,Pizzi M,Meno M,et al.Neuroprotection by aspirin and sodium salicylate through blockade of NF-κB activation[J].Science,1996,274:1383-1385
  • 6Zandi PP,Anthony JC,Hayden KM,et al.Reduced incidence of AD with NSAID but not H2 receptor antagonists:the Cache County Study[J].Neurology,2002,59:880-886
  • 7In t'Veld BA,Ruitenberg A,Hofman A,et al.Nonsteroidal antiinflammatory drugs and the risk of Alzheimer′s disease[J].N Engl J Med,2001,345:1515-1521
  • 8Landi F,Cesari M,Onder G,et al.Non-steroidal anti-inflammatory drug(NSAID)use and Alzheimer disease in community-dwelling elderly patients[J].Am J Geriatr Psychiatry,2003,11:179-185
  • 9Neystat M,Rzhetskaya M,Oo TF,et al.Expression of cyclin-dependent kinase 5 and its activator P35 in models of induced apoptotic death in neurons of the substantia nigra in vivo[J].J Neurochem,2001,77:1611-1625
  • 10Nguyen MD,Lariviere RC,Julien J-P.Deregulation of cdk5 in a mouse model of ALS:toxicity alleviated by perikaryal neurofilament inclusions[J].Neuron,2001,8:135-147

共引文献67

同被引文献75

引证文献4

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部